Hamilton Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
1,006
+8
+0.8% +$8.17K 0.06% 41
2026
Q1
$918K Sell
998
-167
-14% -$169K 0.05% 47
2025
Q4
$1.25M Buy
+1,165
New +$1.11M 0.06% 37
2025
Q2
$892K Buy
1,144
+18
+2% +$14K 0.05% 43
2025
Q1
$930K Buy
1,126
+37
+3% +$30.8K 0.06% 42
2024
Q4
$841K Buy
1,089
+97
+10% +$80.3K 0.06% 43
2024
Q3
$823K Sell
992
-15
-1% -$13.5K 0.06% 46
2024
Q2
$912K Sell
1,007
-149
-13% -$119K 0.07% 33
2024
Q1
$899K Sell
1,156
-46
-4% -$32.7K 0.07% 40
2023
Q4
$700K Sell
1,202
-150
-11% -$87.6K 0.06% 48
2023
Q3
$726K Buy
1,352
+43
+3% +$22.2K 0.06% 43
2023
Q2
$614K Sell
1,309
-58
-4% -$24.3K 0.04% 52
2023
Q1
$470K Sell
1,367
-1,734
-56% -$585K 0.03% 57
2022
Q4
$1.13M Buy
3,101
+2,039
+192% +$723K 0.07% 29
2022
Q3
$343K Buy
1,062
+51
+5% +$16.2K 0.02% 58
2022
Q2
$328K Sell
1,011
-125
-11% -$37.5K 0.02% 70
2022
Q1
$325K Sell
1,136
-141
-11% -$36.3K 0.02% 74
2021
Q4
$353K Buy
1,277
+354
+38% +$89.7K 0.03% 98
2021
Q3
$213K Buy
+923
New +$228K 0.02% 87

Other funds holding LLY

Hamilton Capital's LLY Position: Q2 2026 in Review

Hamilton Capital increased its Eli Lilly (LLY) stake by 0.8% in Q2 2026, buying an estimated $8.17K and bringing the position to 1,006 shares worth $1.21M. The position accounts for 0.06% of the portfolio, ranked #41.

Hamilton Capital first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.25M in Q4 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hamilton Capital held 1,006 shares of Eli Lilly worth $1.21M as of Q2 2026.
  • Hamilton Capital bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.06% of Hamilton Capital's portfolio in Q2 2026, its #41 holding.
  • Hamilton Capital first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
  • Hamilton Capital's Eli Lilly position peaked at $1.25M in Q4 2025.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hamilton Capital's 13F filing for Q2 2026, filed 17 Aug 2026.